ACTICOR BIOTECH
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It... is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.
ACTICOR BIOTECH
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.acticor-biotech.com
Total Employee:
11+
Status:
Active
Contact:
+33970468640
Email Addresses:
[email protected]
Total Funding:
33.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro Microsoft Exchange Online
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Anaxago
Anaxago investment in Series B - Acticor Biotech
Newton Biocapital
Newton Biocapital investment in Series B - Acticor Biotech
A&B (HK)
A&B (HK) investment in Series B - Acticor Biotech
Karista
Karista investment in Series B - Acticor Biotech
Mirae Asset Global Investments
Mirae Asset Global Investments investment in Series B - Acticor Biotech
CMS Medical Venture Investment
CMS Medical Venture Investment investment in Series B - Acticor Biotech
GO CAPITAL
GO CAPITAL investment in Series B - Acticor Biotech
Mirae Capital
Mirae Capital investment in Series B - Acticor Biotech
Newton Biocapital
Newton Biocapital investment in Series B - Acticor Biotech
CMS Medical Venture Investment
CMS Medical Venture Investment investment in Series B - Acticor Biotech
Official Site Inspections
http://www.acticor-biotech.com Semrush global rank: 3.84 M Semrush visits lastest month: 3.42 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
